<DOC>
	<DOCNO>NCT01732081</DOCNO>
	<brief_summary>It estimate 350-400 million people worldwide chronically infect hepatitis B virus ( HBV ) . Cirrhosis hepatocellular carcinoma major complication chronic HBV infection responsible 500,000 deaths year . Although predictive factor outcome chronic HBV infection report , remain need precisely determine factor associate outcome non-selected patient . Indeed , factor help identify patient likely good bad evolution chronic HBV infection time thus , adapt clinical management monitoring.Therefore , purpose constitute `` real-life '' cohort non-selected patient create database epidemiological , clinical , biological , virological therapeutic parameter , order determine factor associate outcome chronic HBV infection .</brief_summary>
	<brief_title>`` Real-life '' Cohort Patients With Chronic Hepatitis B Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Patients chronic HBV infection ( defined HBsAg positive least 6 month ) Coinfection human immunodeficiency virus ( HIV ) , hepatitis C virus ( HCV ) and/or hepatitis D virus ( HDV ) Decompensated cirrhosis History liver transplantation History hepatocellular carcinoma ( HCC )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Hepatitis B</keyword>
</DOC>